openPR Logo
Press release

Neurological Disorder Diagnostics Market Predicts Rise In Demand By 2026 With Increasing Strategic Collaborations For Development Of New Diagnostic Tools By Key Players Healthineers, Koninklijke Philips N.V., General Electric Company, Esaote SpA, NeuroLog

01-29-2019 04:31 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Clinical Diagnostic

Neurological Disorder Diagnostics

Neurological Disorder Diagnostics

Frequent Launches And Approvals Of Novel Neurological Disorder Diagnostics Products Is Expected To Drive Growth Of The Market

In the recent past, key players in the market had received approvals and had launched a number of novel technological advanced neurological disorder diagnosis devices in the market, and this is expected to aid in neurological disorder diagnostics market growth. For instance, in April 2018, Canon Medical Systems Corporation launched 1.5T MRI System, Vantage Orian. In April 2018, Siemens Healthineers received U.S. FDA approval for its new SOMATOM go.All and SOMATOM go.Top computed tomography (CT) systems.

The global neurological disorder diagnostics market was valued at US$ 10,774.6 Mn in 2017, and is expected to witness a CAGR of 7.3% over the forecast period (2018 – 2026).

Download PDF Brochure of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-pdf/1867

Increasing Strategic Collaborations For Development Of New Diagnostic Tools Is Expected To Propel The Market Growth

Strategic collaboration among key players in the market is also expected to be another factor fueling growth of the global neurological disorder diagnosis market growth. For instance, in March 2018, Canon Medical Systems, Kumamoto University, and University of Bordeaux entered into collaborative research for development of deep learning technology in magnetic resonance imaging. In 2017, York Instruments Ltd. signed an agreement for three Magnetoencephalography Systems with three leading universities. The University of York, the University of Glasgow in the U.K., and Germany’s University of Konstanz partnered with York Instruments to develop this technology.

High cost of diagnostic tools such as MRI machines and CT scan is a major factor, which is expected to hinder growth of global neurological disorder diagnostics market. Devices of such high cost are not affordable by small hospital facilities in emerging economies such as India, Africa, and China. Therefore, this factor is expected to negatively affect growth of the market.

Detailed Segmentation:

Global Neurological disorder diagnostics, By Technology : Imaging, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Nuclear Medicine Imaging, Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT), Near Infrared Spectroscopic Imaging (NIRS), Electroencephalography (EEG), Magnetoencephalography (MEG), In Vitro Diagnostics, Biomarker, Biopsy, Others.

Global Neurological disorder diagnostics, By Disease Indication:
Genetic Neurological Disorders: Alzheimer’s Disease (AD), Parkinson’s Disease (PD), Amyotrophic Lateral Sclerosis (ALS), Huntington's Disease (HD), Others.
Immunological Neurological Disorders: Multiple Sclerosis, Others,
Paraneoplastic Syndrome,
Paraproteinemic neuropathies,
Others.

Competitive Landscape

Key players operating in the neurological disorder diagnostics market include Healthineers, Koninklijke Philips N.V., General Electric Company, Esaote SpA, NeuroLogica Corporation, Masimo Corporation, York Instruments Ltd., Neusoft Medical Systems, and Canon Medical Systems Corporation

Else, Place an Enquiry To Talk With Out Analyst : https://www.coherentmarketinsights.com/insight/talk-to-analyst/1867

Global Neurological disorder diagnostics, By End User: Hospitals & Clinics, Diagnostic Centers, Ambulatory Care Centers.

Neurological disorder diagnostic tools are those used in diagnosis of various neurological disorders. Neurological disorders can be diagnosed with the use of imaging and in vitro diagnostics techniques. Imaging techniques such as Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) are used to create detailed images of organs, bones, soft tissue, blood vessels and different parts of body, while vitro diagnostic techniques consists of techniques such as biopsy, biomarker, blood test, urine test, and genetic testing.

Market Dynamics

Product launches and approvals of novel neurological diagnostic products is expected to be a major driver for growth of the global neurological disorder diagnostics. For instance, in 2016, Koninklijke Philips N.V. launched its latest Philips IQon Spectral CT in Canada. The latest Philips IQon Spectral CT is the world’s first and only spectral detector CT, designed specifically for spectral imaging. With a new dual-layer spectral detector, the IQon Spectral CT has added spectral resolution to conventional CT scanning. Increasing research and development activities for development of novel diagnosis techniques for neurological disorder is also expected to fuel the market growth.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurological Disorder Diagnostics Market Predicts Rise In Demand By 2026 With Increasing Strategic Collaborations For Development Of New Diagnostic Tools By Key Players Healthineers, Koninklijke Philips N.V., General Electric Company, Esaote SpA, NeuroLog here

News-ID: 1543033 • Views: 319

More Releases from Coherent Market Insights - Clinical Diagnostic

Western Blotting Market is Expected to Gain Popularity Across the Globe by 2026
Western blotting is a technique used for detection of protein. It is also called as immunoblotting technique wherein specific antibodies are used to detect antigens. It works on the principle of molecular weight of the proteins and specificity. Gel electrophoresis is used for the denaturation of proteins and to obtain the primary antibody. Blotting and testing is performed later where the primary antibody binds to its specific antigen. It gives
Western Blotting Market: Future and Technological Advancement 2026 By Top Player …
Western blotting is a technique used for detection of protein. It is also called as immunoblotting technique wherein specific antibodies are used to detect antigens. It works on the principle of molecular weight of the proteins and specificity. Gel electrophoresis is used for the denaturation of proteins and to obtain the primary antibody. Blotting and testing is performed later where the primary antibody binds to its specific antigen. It gives
Cannabis Testing Market Expansion to be Persistent During 2018 – 2026 With Top …
Cannabis testing is done for various purpose such as finding concentration of active ingredient (cannabinoids, terpene), which determines the medical potency of the cannabis. It is also tested for determining various other ingredient in given sample. For instance, to determine the pesticide residue content in the given sample that undermines the purity and efficacy. Cannabis testing also involves determination of contaminants such as fungi and bacteria (mycotoxins), which could causes
Cannabis Testing Market Trends Estimates High Demand By 2026 With Top Key Player …
Cannabis testing products and services market is witnessing significant growth with increased government approval and loosening regulatory stringent ness over use of cannabis for commercial and recreational purpose. For instance, in February 2016, the Australian government amended the Narcotics Drugs Act 1967, to allow cultivation of cannabis for medicinal or scientific purposes under a national licensing scheme, which is expected to favor the growth of the commercial manufacturing of cannabis

All 5 Releases


More Releases for Neurological

Neurological Biomarkers Market - Sophisticated Demand 2025 | QIAGEN N.V., Athena …
Global Neurological Biomarkers Market: Snapshot The population of people affected by a number of neurological conditions has expanded at a rapid pace in the past few years across the globe, making these diseases a leading cause of disability. For the better understanding of these conditions and for the development of more effective personalized medicines, neurology biomarkers have thus been gaining increased attention from the world research fraternity. Request Sample Copy of the
Neurological Biomarkers Market - Product benefits 2025 | Cisbio Bioassays, Prote …
Global Neurological Biomarkers Market: Snapshot The population of people affected by a number of neurological conditions has expanded at a rapid pace in the past few years across the globe, making these diseases a leading cause of disability. For the better understanding of these conditions and for the development of more effective personalized medicines, neurology biomarkers have thus been gaining increased attention from the world research fraternity. Request Sample Copy of the
7th International Conference on Neurological Disorders & Stroke
Greetings from Stroke Congress 2018!! We are writing to request all your presence to our CME accredited event as our eminent Speaker for the upcoming “7th International Conference on Neurological Disorders & Stroke (Stroke Congress 2018)” scheduled to be held on September 20-21, 2018 in Rome, Italy. The theme of the conference is Melioration in Innovations with advancement in Neurological disorders and Stroke to create awareness on the current needs &
Neurological Disorder Drugs Market – Latest Report with Forecast to 2024
The Europe neurological disorder drugs market has been anticipated in a report by Transparency Market Research (TMR) to uphold a consolidated nature as small companies have been researched to secure a strong share. A maximum amount of revenue had been bagged by five leading companies of the market in the recent past: GlaxoSmithKline plc, Novartis AG, AstraZeneca, Bayer AG, and Merck & Co. Most of these companies have been foreseen
Neurological Biomarkers Market Competition Insights 2025
Global Neurological Biomarkers Market: Overview This report on the global neurological biomarkers market is a comprehensive market intelligence study that brings forth the lucrativeness of the said market. Beginning with an executive summary that comprise a snapshot of how the demand for neurological biomarkers has evolved over the recent past and where is it headed to in the future, the report delves into the analysis of various market dynamics, such as
Neurological Biomarkers Market: Pipeline Overview 2017 - 2025
Biomarkers are biological markers which measure the biological states. It is used for indicating the normal biological and pathogenic process to a therapeutic intervention. These biomarkers can also be used in combination to access disease state of an individual. Scientists are exploring more about the structural and functional differences of the neurological diseases. Moreover, there has been an increase in biobanks which have help address unmet needs in oncology, neuroscience,